Cardlytics Continues Income Contraction Amid Worsening Business Economics (NASDAQ: CDLX)

.Financial author highly recommends selling Cardlytics, Inc. because of declining system economics, profits difficulties, and negative financial styles. Click on for this CDLX improve.